MGRX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Mangoceuticals Inc (MGRX) is not a good buy for a beginner, long-term investor at this time. The stock lacks strong positive catalysts, has weak financial performance, and no clear trading signals. Additionally, the technical analysis indicates bearish trends, and there is no recent news or analyst support to justify a long-term investment.
The technical indicators show a bearish trend with moving averages in the order SMA_200 > SMA_20 > SMA_5. The RSI is neutral at 29.921, and the MACD histogram is slightly positive at 0.0192 but contracting. Key support levels are at 0.346 and 0.32, while resistance levels are at 0.431 and 0.457. The stock is currently trading pre-market at 0.475, which is above the resistance levels, but this price surge lacks supporting catalysts.
NULL identified. There is no recent news, no significant insider or hedge fund trading activity, and no congress trading data available.
The company's financial performance in Q3 2025 is weak, with a significant YoY revenue drop (-36.83%) and a negative EPS (-0.69, down 95.35% YoY). Gross margin also declined slightly (-2.53%). The stock's historical trend suggests a potential short-term decline (-1.4% next day, -2.06% next week).
In Q3 2025, the company reported a revenue drop of -36.83% YoY to 84,246. Net income improved to -7,912,218 (up 295.76% YoY), but the EPS dropped significantly to -0.69 (-95.35% YoY). Gross margin also fell slightly to 60.42 (-2.53% YoY). Overall, the financials indicate weak growth and profitability.
No analyst rating or price target data available.
